We are live on ! Find out more
NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV

Delisted

NBRV was delisted on the 31st of July, 2023.

Back to rankings

33 hedge funds and large institutions have $8.73M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

686% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $279K

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

33% less funds holding

Funds holding: 49 → 33 (-16)

47% less capital invested

Capital invested by funds: $16.4M → $8.73M (-$7.66M)

62% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 26

Holders
33
Holders Change
-16
Holders Change %
-32.65%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
7
Reduced
8
Closed
26
Calls
$2.19M
Puts
$279K
Net Calls
+$1.91M
Net Calls Change
+$973K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.56M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.47M
3
SM
Sabby Management
Florida
+$1.01M
4
GCP
GSA Capital Partners
United Kingdom
+$219K
5
VF
Virtu Financial
New York
+$95.6K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$1.41M
2
RSCM
Rock Springs Capital Management
Maryland
-$569K
3
IWC
Integrated Wealth Concepts
Massachusetts
-$172K
4
WG
Winton Group
United Kingdom
-$160K
5
KPWS
Kestra Private Wealth Services
Texas
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
26
Steward Partners Investment Advisory
New York
$2K – – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K -$217 -2 -9%
CFD
28
Creative Financial Designs
Indiana
$1K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$1K – – –
EC
30
Estate Counselors
Wisconsin
$1K +$1.95K +18 New
Hudson Bay Capital Management
31
Hudson Bay Capital Management
Connecticut
– -$55K -21,814 Closed
O
32
OrbiMed
New York
– -$1.41M -10,578 Closed
RSCM
33
Rock Springs Capital Management
Maryland
– -$569K -4,271 Closed
IWC
34
Integrated Wealth Concepts
Massachusetts
– -$172K -1,288 Closed
ED
35
Exane Derivatives
France
– -$71.9K -540 Closed
Commonwealth Equity Services
36
Commonwealth Equity Services
Massachusetts
– -$38K -288 Closed
Creative Planning
37
Creative Planning
Kansas
– -$35K -264 Closed
Geode Capital Management
38
Geode Capital Management
Massachusetts
– -$33K -251 Closed
Goldman Sachs
39
Goldman Sachs
New York
– -$30K -226 Closed
MP
40
MSD Partners
New York
– -$27K -200 Closed
Millennium Management
41
Millennium Management
New York
– -$20 -153 Closed
OSAM
42
O'Shaughnessy Asset Management
Connecticut
– -$20K -152 Closed
RWM
43
Ritholtz Wealth Management
New York
– -$20K -152 Closed
RJA
44
Raymond James & Associates
Florida
– -$20K -149 Closed
Deutsche Bank
45
Deutsche Bank
Germany
– -$14K -106 Closed
BF
46
BOK Financial
Oklahoma
– -$13K -100 Closed
WS
47
Wedbush Securities
California
– -$11K -84 Closed
GF
48
Gabelli Funds
New York
– -$9K -70 Closed
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
– -$7.58K -70 Closed
First Manhattan
50
First Manhattan
New York
– -$6K -50 Closed
1
2
3

NBRV Hedge Fund Activity: Q4 2020 in Review

33 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q4 2020, worth a combined $8.73M — down 47% from $16.4M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of NBRV and 10 opened new positions — a net loss of 16 holders — while 8 trimmed existing stakes and 7 added.

The largest buyer was Morgan Stanley, adding an estimated $1.56M. The largest seller was OrbiMed, exiting entirely with an estimated $1.41M sold.

  • 33 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q4 2020, down from 49 in Q3 2020.
  • Funds reported $8.73M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q4 2020, down 47% quarter-over-quarter.
  • 10 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q4 2020 and 26 closed out, a net change of -16 holders.
  • The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q4 2020 was Morgan Stanley, an estimated $1.56M added.
  • The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q4 2020 was OrbiMed, an estimated $1.41M sold.

Based on aggregated 13F filings for Q4 2020.